Epidemiological Assessment of Eight Rounds of Mass Drug Administration for Lymphatic Filariasis in India: Implications for Monitoring and Evaluation

PLoS Neglected Tropical Diseases

Volumn 6, Issue 11, 2012, Pages

  Swaminathan, Subramanian ^a   Perumal, Vanamail ^a   Adinarayanan, Srividya ^a   Kaliannagounder, Krishnamoorthy ^a   Rengachari, Ravi ^a   Purushothaman, Jambulingam ^a  

^a VECTOR CONTROL RESEARCH CENTRE   (India)

Author keywords

[No Author keywords available]

Indexed keywords

ALBENDAZOLE; DIETHYLCARBAMAZINE; IVERMECTIN; VIRUS ANTIGEN;

ADOLESCENT; ADULT; AGE; ANTIGEN DETECTION; ARTICLE; CHILD; CONTROLLED STUDY; DRUG EFFICACY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GENDER; HEALTH PROGRAM; HEALTH SURVEY; HOUSEHOLD; HUMAN; INDIA; LYMPHATIC FILARIASIS; MALE; MASS DRUG ADMINISTRATION; MASS SCREENING; MICROFILARIA; MONITORING; PERSONAL DIGITAL ASSISTANT; PRESCHOOL CHILD; PREVALENCE; PRIMARY HEALTH CARE; SCHOOL CHILD;

ADULT; AGED; AGED, 80 AND OVER; ANIMALS; ANTIGENS, HELMINTH; CHILD; CHILD, PRESCHOOL; DRUG MONITORING; DRUG THERAPY; ELEPHANTIASIS, FILARIAL; FEMALE; FILARICIDES; HEALTH SERVICES RESEARCH; HUMANS; INDIA; INFANT; INFANT, NEWBORN; MALE; MIDDLE AGED; PREVALENCE; YOUNG ADULT;

EID: 84870744454     PISSN: 19352727     EISSN: 19352735     Source Type: Journal    
DOI: 10.1371/journal.pntd.0001926     Document Type: Article

References (27)

1. World Health Organization (2011) Global Programme to Eliminate Lymphatic Filariasis: progress report on mass drug administration, 2010. Wkly Epidemiol Rec 86: 377-388.
2. World Health Organization (2005) Monitoring and epidemiological assessment of the programme to eliminate lymphatic filariasis at implementation unit level. WHO/CDS/CPE/CEE/2005.50.
3. World Health Organization (2010) Global programme to eliminate lymphatic filariasis - Progress report on mass drug administration in 2009. Wkly Epidemiol Rec 85: 365-372.
4. World Health Organization (2011) Monitoring and epidemiological assessment of mass drug administration in the global programme to eliminate lymphatic filariasis: a manual for national elimination programmes. WHO/HTM/NTD/PCT/2011.4: 1-79.
5. Xu B, Cui Z, Zhang Y, Chang J, Zhao Q, et al. (1997) Studies on the transmission potential of surviving microfilaraemias after basic control of filariasis. Southeast Asian J Trop Med Public Health 28: 308-313.
6. Ramaiah KD, Thiruvengadam B, Vanamail P, Subramanian S, Gunasekaran S, et al. (2009) Prolonged persistence of residual Wuchereria bancrofti infection after cessation of diethylcarbamazine-fortified salt programme. Trop Med Int Health 14: 870-876.
7. Ramaiah KD, Vanamail P, Yuvaraj J, Das PK, (2011) Effect of annual mass administration of diethylcarbamazine and albendazole on bancroftian filariasis in five villages in south India. Trans R Soc Trop Med Hyg 105: 431-437.
8. Michael E, Malecela-Lazaro MN, Kabali C, Snow LC, Kazura JW, (2006) Mathematical models and lymphatic filariasis control: endpoints and optimal interventions. Trends Parasitol 22: 226-233.
9. Ramzy RM, El Setouhy M, Helmy H, Ahmed ES, Abd Elaziz KM, et al. (2006) Effect of yearly mass drug administration with diethylcarbamazine and albendazole on bancroftian filariasis in Egypt: a comprehensive assessment. Lancet 367: 992-999.
10. Rajagopalan PK, Das PK, Subramanian S, Vanamail P, Ramaiah KD, (1989) Bancroftian filariasis in Pondicherry, south India: 1. Pre-control epidemiological observations. Epidemiol Infect 103: 685-692.
11. Subramanian S, Pani SP, Das PK, Rajagopalan PK, (1989) Bancroftian filariasis in Pondicherry, south India: 2. Epidemiological evaluation of the effect of vector control. Epidemiol Infect 103: 693-702.
12. Kumar A, Yadav VS, Katoch K, Sachan P, (2006) Filariasis in Ghatampur Tahsil of Kanpur Nagar District: indications of high endemicity locus. Journal of Communicable Diseases 38: 155-159.
13. Sunish IP, Rajendran R, Satyanarayana K, Munirathinam A, Gajanana A, (2001) Immunochromatographic test (ICT) for estimation of true prevalence of bancroftian filariasis in an endemic area in southern India. Trans R Soc Trop Med Hyg 95: 607-609.
14. Steel C, Ottesen EA, Weller PF, Nutman TB, (2001) Worm burden and host responsiveness in Wuchereria bancrofti infection: use of antigen detection to refine earlier assessments from the South Pacific. Am J Trop Med Hyg 65: 498-503.
15. Watanabe K, Itoh M, Matsuyama H, Hamano S, Kobayashi S, et al. (2003) Bancroftian filariasis in Nepal: a survey for circulating antigenemia of Wuchereria bancrofti and urinary IgG4 antibody in two rural areas of Nepal. Acta Trop 88: 11-15.
16. Chandra G, Chatterjee SN, Das S, Sarkar N, (2007) Lymphatic filariasis in the coastal areas of Digha, West Bengal, India. Trop Doct 37: 136-139.
17. Kyelem D, Biswas G, Bockarie MJ, Bradley MH, El-Setouhy M, et al. (2008) Determinants of success in national programs to eliminate lymphatic filariasis: a perspective identifying essential elements and research needs. Am J Trop Med Hyg 79: 480-484.
18. Bal MS, Beuria MK, Mandal NN, Das MK, (2009) Antigenemia in young children living in Wuchereria bancrofti-endemic areas of Orissa, India. Trans R Soc Trop Med Hyg 103: 262-265.
19. Lammie PJ, Hightower AW, Eberhard ML, (1994) Age-specific prevalence of antigenemia in a Wuchereria bancrofti-exposed population. Am J Trop Med Hyg 51: 348-355.
20. Ramaiah KD, Das PK, Vanamail P, Pani SP, (2007) Impact of 10 years of diethylcarbamazine and ivermectin mass administration on infection and transmission of lymphatic filariasis. Trans R Soc Trop Med Hyg 101: 555-563.
21. Richards FO Jr, Eigege A, Miri ES, Kal A, Umaru J, et al. (2011) Epidemiological and Entomological Evaluations after Six Years or More of Mass Drug Administration for Lymphatic Filariasis Elimination in Nigeria. PLoS Negl Trop Dis 5 (10):: e1346 doi:10.1371/journal.pntd.0001346.
22. Boyd A, Won KY, McClintock SK, Donovan CV, Laney SJ, et al. (2010) A community-based study of factors associated with continuing transmission of lymphatic filariasis in Leogane, Haiti. PLoS Negl Trop Dis 4: e640.
23. Washington CH, Radday J, Streit TG, Boyd HA, Beach MJ, et al. (2004) Spatial clustering of filarial transmission before and after a Mass Drug Administration in a setting of low infection prevalence. Filaria J 3: 3.
24. Bonfim C, Netto MJ, Pedroza D, Portugal JL, Medeiros Z, (2009) A socioenvironmental composite index as a tool for identifying urban areas at risk of lymphatic filariasis. Trop Med Int Health 14: 877-884.
25. Bonfim C, Alves A, Costa TR, Alencar F, Pedroza D, et al. (2011) Spatial analysis and privation index to identify urban areas with a high risk of lymphatic filariasis. Trop Med Int Health 16: 748-755.
26. Vanamail P, Subramanian S, Das PK, Pani SP, Bundy DAP, (1989) Familial-clustering in Wuchereria bancrofti infection. Tropical Biomedicine 6: 67-71.
27. Vanamail P, Ramaiah KD, Krishnamoorthy K, Pani SP, Das PK, (1992) Distribution of microfilaria carriers and clinical cases of bancroftian filariasis in relation to family size in an urban situation. Tropical Biomedicine 9: 91-98.